Shiu-Feng Huang Selected Research

Phosphotransferases (Kinase)

7/2012	Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study.
12/2007	MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.
9/2006	Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer.
12/2004	High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.
10/2003	Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiu-Feng Huang Research Topics

Disease

55	Neoplasms (Cancer) 09/2022 - 08/2003
20	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2003
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 12/2004
8	Adenocarcinoma of Lung 01/2017 - 12/2004
6	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2007
6	Liver Neoplasms (Liver Cancer) 01/2022 - 02/2009
6	Fibrosis (Cirrhosis) 01/2014 - 10/2004
5	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2004
5	Adenocarcinoma 12/2011 - 02/2006
4	Carcinogenesis 03/2022 - 02/2006
3	Fatty Liver 10/2021 - 05/2012
3	Neuroblastoma 11/2019 - 11/2004
3	Chronic Hepatitis B 07/2019 - 01/2009
3	Leukemia 01/2019 - 05/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 10/2004
3	Breast Neoplasms (Breast Cancer) 01/2013 - 01/2005
3	Chronic Hepatitis (Chronic Active Hepatitis) 05/2012 - 11/2007
3	Hypermethioninemia 05/2012 - 11/2007
2	Non-alcoholic Fatty Liver Disease 10/2021 - 05/2012
2	Infections 01/2021 - 01/2009
2	COVID-19 01/2021 - 01/2020
2	Liver Diseases (Liver Disease) 01/2021 - 07/2019
2	Chronic Hepatitis C 07/2019 - 09/2008
2	Hepatitis B 01/2019 - 04/2015
2	Hepatitis 01/2019 - 04/2015
2	Pleural Effusion (Pleural Effusions) 06/2015 - 03/2010
2	Respiratory Insufficiency (Respiratory Failure) 11/2013 - 04/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2012 - 12/2010
2	Disease Progression 03/2012 - 03/2004
2	Cholangiocarcinoma 02/2006 - 04/2005
2	Carcinoma (Carcinomatosis) 04/2005 - 10/2003
2	Carcinoma in Situ 12/2004 - 10/2004
1	Alcoholic Fatty Liver 10/2021
1	Inflammation (Inflammations) 10/2021
1	Body Weight (Weight, Body) 01/2021
1	Liver Failure 01/2021
1	Virus Diseases (Viral Diseases) 01/2019

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 06/2022 - 07/2003
14	ErbB Receptors (EGF Receptor)IBA 07/2015 - 12/2004
13	Messenger RNA (mRNA)IBA 01/2017 - 03/2008
6	Biomarkers (Surrogate Marker)IBA 11/2019 - 03/2008
6	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 01/2018 - 11/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2007
5	Tyrosine Kinase InhibitorsIBA 07/2015 - 09/2008
5	Phosphotransferases (Kinase)IBA 07/2012 - 10/2003
5	Gefitinib (Iressa)FDA Link 12/2007 - 12/2004
4	Biological ProductsIBA 01/2021 - 01/2006
4	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2012
4	Pharmaceutical PreparationsIBA 06/2015 - 01/2006
4	ParaffinIBA 07/2012 - 11/2004
3	Nonsense Codon (Nonsense Mutation)IBA 09/2022 - 01/2009
3	Transcription Factors (Transcription Factor)IBA 02/2022 - 11/2004
3	Alanine Transaminase (SGPT)IBA 01/2021 - 11/2007
3	CytokinesIBA 01/2021 - 06/2015
3	Indicators and Reagents (Reagents)IBA 01/2020 - 05/2010
3	Antiviral Agents (Antivirals)IBA 06/2018 - 09/2008
3	Small Interfering RNA (siRNA)IBA 08/2014 - 03/2010
3	Coloring Agents (Dyes)IBA 01/2013 - 08/2003
3	Methionine (L-Methionine)FDA Link 05/2012 - 11/2003
3	CholesterolIBA 05/2012 - 07/2003
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2012 - 12/2007
2	Insulin (Novolin)FDA Link 10/2021 - 07/2005
2	AntigensIBA 12/2018 - 01/2013
2	LigandsIBA 10/2016 - 04/2010
2	Complement System Proteins (Complement)IBA 04/2016 - 04/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015 - 10/2004
2	EnzymesIBA 01/2013 - 09/2005
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2009 - 09/2008
2	Threonine (L-Threonine)FDA Link 12/2007 - 11/2003
2	AcidsIBA 04/2006 - 05/2004
2	MucinsIBA 02/2006 - 07/2003
2	Cyclin D1IBA 04/2005 - 12/2004
1	A-factor (Streptomyces)IBA 03/2022
1	C-Type Lectins (C-Type Lectin)IBA 03/2022
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Monounsaturated Fatty AcidsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Interleukin-13IBA 01/2022
1	L 644711 (B-3(+))IBA 10/2021
1	Pioglitazone (Actos)FDA Link 10/2021
1	nasIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 07/2021
1	NucleoproteinsIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Amylases FDA Link 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Viral RNAIBA 01/2021
1	VaccinesIBA 01/2021
1	KynurenineIBA 11/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2003
5	Drug Therapy (Chemotherapy) 01/2016 - 11/2004
3	Immunotherapy 01/2022 - 08/2006
2	Hepatectomy 05/2010 - 03/2007